WebSep 4, 2012 · Silja Conradi 1, 2, 5, Uwe Malzahn 3, 8, Friedemann Paul 2, 4, Sabine Quill 1, 2, Lutz Harms 1, 2, Florian Then Bergh 5, Anna Ditzenbach 6, Thomas Georgi 7, Peter Heuschmann 3, 8, Berit Rosche 1, 2 1 Department of Neurology and Experimental Neurology, Charité – Universitätsmedizin Berlin, Germany WebSibyl Wray 1 , Florian Then Bergh 2 , Annette Wundes 3 , Douglas L Arnold 4 5 , Jelena Drulovic 6 , Elzbieta Jasinska 7 , James D Bowen 8 , Donald Negroski 9 , Robert T …
Monthly intravenous methylprednisolone in relapsing-remitting multiple ...
WebApr 8, 2014 · Then Bergh has received research support from Bayer Schering, Novartis and Teva Neuroscience. Tuesday, April 29 2014, 3:00 pm-6:30 pm Pilot Trial Of Recombinant Human Growth Hormone For Remyelination In Multiple Sclerosis: Current Status And Preliminary Safety Analysis (P3.155) Neurology WebBibTeX @MISC{Michalski_mentalillness, author = {Dominik Michalski and Stefanie Liebig and Eva Thomae and Susanne Singer and Andreas Hinz and Florian Then Bergh}, title = {Mental Illness 2010; volume 2:e5 Anxiety, depression and}, year = {}} css prefers color scheme
Author Page for Florian Then Bergh :: SSRN
WebApr 6, 2015 · Then Bergh has received personal compensation for activities with Biogen Idec, Novartis, Merck Serono, and Sanofi-Aventis Pharmaceuticals, Inc. as a speaker and/or advisory board member. Monday, April 20 2015, 2:00 pm-6:30 pm WebFlorian Then Bergh, Florian Then Bergh. Present address: Department of Neurology, University of Leipzig, Leipzig, Germany. Search for more papers by this author. Tania Kümpfel, Tania Kümpfel. Present address: Institute of Clinical Neuroimmunology, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany. WebObjective: This study assessed arousal regulation in multiple sclerosis patients, explored if fatigue can be physiologically described by altered arousal regulation, and if HPA axis … earls online booking